Overall, results of this study suggested that a latent myeloproliferative disorder, which eventually could have been disclosed by detection of the JAK2V617F allele, is very unlikely to underlie such unusual thrombotic manifestations as are retinal vein thrombosis or recurrent fetal loss, which probably have different mechanisms
JAK2V617F mutational screening in patients with retinal vein thrombosis or recurrent fetal loss / P. Guglielmelli; C. Fatini; M. Lenti; A. Bosi; A.M. Vannucchi. - In: THROMBOSIS RESEARCH. - ISSN 0049-3848. - STAMPA. - 124:(2009), pp. 377-378. [10.1016/j.thromres.2008.11.002]
JAK2V617F mutational screening in patients with retinal vein thrombosis or recurrent fetal loss.
GUGLIELMELLI, PAOLA;FATINI, CINZIA;BOSI, ALBERTO;VANNUCCHI, ALESSANDRO MARIA
2009
Abstract
Overall, results of this study suggested that a latent myeloproliferative disorder, which eventually could have been disclosed by detection of the JAK2V617F allele, is very unlikely to underlie such unusual thrombotic manifestations as are retinal vein thrombosis or recurrent fetal loss, which probably have different mechanismsFile in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
guglielmelli_thrombResearc2009.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
108.72 kB
Formato
Adobe PDF
|
108.72 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.